Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI Worldwide, MilanCPhI Worldwide, Milan
Not Confirmed
Not Confirmed
08-10 October, 2024
Discovery on TargetDiscovery on Target
Not Confirmed
Not Confirmed
30 September-03 October, 2024
Not Confirmed
Not Confirmed
30 September-02 October, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI Worldwide, MilanCPhI Worldwide, Milan
Industry Trade Show
Not Confirmed
08-10 October, 2024
Discovery on TargetDiscovery on Target
Industry Trade Show
Not Confirmed
30 September-03 October, 2024
Industry Trade Show
Not Confirmed
30 September-02 October, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/ice-is-pioneering-sustainability-innovation-in-bile-acid-research-for-neurodegenerative-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/2024-us-elections-harris-trump-differ-on-abortion-rights-aca-public-health-spends-agree-on-need-to-cut-drug-prices
26 May 2021
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2021/05/26/2236903/0/en/Knight-Therapeutics-Announces-Closing-of-Previously-Announced-Acquisition-and-Exclusive-License-to-Exelon-in-Canada-and-Latin-America.html#:~:text=(TSX%3A%20GUD)%20(%22,as%20well%20as%20an%20exclusive
23 Apr 2021
// GLOBENEWSWIRE
http://www.globenewswire.com/news-release/2021/04/23/2215925/0/en/Knight-Therapeutics-to-Acquire-Regional-Rights-to-Exelon.html
01 Mar 2021
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2021/03/02/2184801/0/en/Knight-Therapeutics-Announces-Canadian-Commercial-Launch-of-IBSRELA-New-Innovative-Treatment-for-Irritable-Bowel-Syndrome-with-Constipation.html
21 Sep 2020
// BUSINESSWIRE
03 Sep 2020
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2020/09/03/2088839/0/en/Knight-Therapeutics-Announces-Filling-of-Supplement-to-a-New-Drug-Submission-for-NERLYNX-neratinib-to-Treat-HER2-Positive-Metastatic-Breast-Cancer.html
25 Aug 2020
// BUSINESSWIRE
https://www.businesswire.com/news/home/20200825005037/en/Knight-TherapeuticsMD-Announce-Health-Canada-Approval-IMVEXXY%C2%AE#:~:text=(NASDAQ%3A%20TXMD)%20(%E2%80%9C,IMVEXXY%C2%AE%20by%20Health%20Canada.&text=Knight%20and%20TherapeuticsMD%20signed%20a,(estradiol%20and%20progesterone)%20capsules.
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?